<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR1304.html">Part 1304
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 1304.33  Reports to Automation of Reports and Consolidated
                            </h3>
                            <p class="depth1"><em>(a)</em> Reports generally. All reports required by this section shall be  filed with the ARCOS Unit on DEA Form 333, or on media which contains  the data required by DEA Form 333 and which is acceptable to the ARCOS  Unit. See the Table of DEA Mailing Addresses in Sec. 1321.01 of this  chapter for the current mailing address.</p><p class="depth1"><em>(b)</em> Frequency of reports. Acquisition/Distribution transaction  reports shall be filed every quarter not later than the 15th day of the  month succeeding the quarter for which it is submitted; except that a  registrant may be given permission to file more frequently (but not more  frequently than monthly), depending on the number of transactions being  reported each time by that registrant. Inventories shall provide data on  the stocks of each reported controlled substance on hand as of the close  of business on December 31 of each year, indicating whether the  substance is in storage or in process of manufacturing. These reports  shall be filed not later than January 15 of the following year.  Manufacturing transaction reports shall be filed annually for each  calendar year not later than January 15 of the following year, except  that a registrant may be given permission to file more frequently (but  not more frequently than quarterly).</p><p class="depth1"><em>(c)</em> Persons reporting. For controlled substances in Schedules I, II,  narcotic controlled substances in Schedule III, and gamma-hydroxybutyric  acid drug product controlled substances in Schedule III, each person who  is registered to manufacture in bulk or dosage form, or to package,  repackage, label or relabel, and each person who is registered to  distribute, including each person who is registered to reverse  distribute, shall report acquisition/distribution transactions. In  addition to reporting acquisition/distribution transactions, each person  who is registered to manufacture controlled substances in bulk or dosage  form shall report manufacturing transactions on controlled substances in  Schedules I and II, each narcotic controlled substance listed in  Schedules III, IV, and V, gamma-hydroxybutyric acid drug product  controlled substances in Schedule III, and on each psychotropic  controlled substance listed in Schedules III and IV as identified in  paragraph (d) of this section.</p><p class="depth1"><em>(d)</em> Substances covered. </p><p class="depth2"><em>(1)</em> Manufacturing and acquisition/ distribution transaction reports shall include data on each controlled  substance listed in Schedules I and II, on each narcotic controlled  substance listed in Schedule III (but not on any material, compound,  mixture or preparation containing a quantity of a substance having a  stimulant effect on the central nervous system, which material,  compound, mixture or preparation is listed in Schedule III or on any  narcotic controlled substance listed in Schedule V), and on gamma- hydroxybutyric acid drug products listed in Schedule III. Additionally,  reports on manufacturing transactions shall include the following  psychotropic controlled substances listed in Schedules III and IV:</p><p class="depth3"><em>(i)</em> Schedule III</p><p class="depth4"><em>(A)</em> Benzphetamine;</p><p class="depth4"><em>(B)</em> Cyclobarbital;</p><p class="depth4"><em>(C)</em> Methyprylon; and</p><p class="depth4"><em>(D)</em> Phendimetrazine.</p><p class="depth3"><em>(ii)</em> Schedule IV</p><p class="depth4"><em>(A)</em> Barbital;</p><p class="depth4"><em>(B)</em> Diethylpropion (Amfepramone);</p><p class="depth4"><em>(C)</em> Ethchlorvynol;</p><p class="depth4"><em>(D)</em> Ethinamate;</p><p class="depth4"><em>(E)</em> Lefetamine (SPA);</p><p class="depth4"><em>(F)</em> Mazindol;</p><p class="depth4"><em>(G)</em> Meprobamate;</p><p class="depth4"><em>(H)</em> Methylphenobarbital;</p><p class="depth4"><em>(I)</em> Phenobarbital;</p><p class="depth4"><em>(J)</em> Phentermine; and</p><p class="depth4"><em>(K)</em> Pipradrol.</p><p class="depth2"><em>(2)</em> Data shall be presented in such a manner as to identify the  particular form, strength, and trade name, if any, of the product  containing the controlled substancefor which the report is being made.  For this purpose, persons filing reports shall utilize the National Drug  Code Number assigned to the product under the National Drug Code System  of the Food and Drug Administration.</p><p class="depth1"><em>(e)</em> Transactions reported. Acquisition/distribution transaction  reports shall provide data on each acquisition to inventory (identifying  whether it is, e.g., by purchase or transfer, return from a customer, or  supply by the Federal Government) and each reduction from inventory  (identifying whether it is, e.g., by sale or transfer, theft,  destruction or seizure by Government agencies). Manufacturing reports  shall provide data on material manufactured, manufacture from other  material, use in manufacturing other material and use in producing  dosage forms.</p><p class="depth1"><em>(f)</em> Exceptions. </p><p class="depth2"><em>(1)</em> A registered institutional practitioner that  repackages or relabels exclusively for distribution or that distributes  exclusively to (for dispensing by) agents, employees, or affiliated  institutional practitioners of the registrant may be exempted from  filing reports under this section by applying to the ARCOS Unit of the  Administration.</p><p class="depth2"><em>(2)</em> Registrants that acquire recalled controlled substances from  ultimate users pursuant to Sec. 1317.85 of this chapter may report as a  single transaction all recalled controlled substances of the same name  and finished form (e.g., all 10-milligram tablets or all 5-milligram  concentration per fluid ounce or milliliter) received from ultimate  users for the purpose of reporting acquisition transactions.</p><p class="depth1"><em>(g)</em> Exemptions. </p><p class="depth2"><em>(1)</em> Collectors that acquire controlled substances  from ultimate users are exempt from the ARCOS reporting requirements  only with respect to controlled substances collected through mail-back  programs and collection receptacles for the purpose of disposal.</p><p class="depth2"><em>(2)</em> Reverse distributors and distributors that acquire controlled  substances pursuant to Sec. 1317.55(a) or (b) of this chapter are  exempt from the ARCOS reporting requirements in this section with regard  to any controlled substances acquired pursuant to Sec. 1317.55(a) or  (b) of this chapter.  (Approved by the Office of Management and Budget under control number  1117-0003)  [62 FR 13962, Mar. 24, 1997, as amended at 68 FR 41229, July 11, 2003;  70 FR 294, Jan. 4, 2005; 75 FR 10678, Mar. 9, 2010; 79 FR 53564, Sept.  9, 2014]</p><p class="depth3">Online Pharmacies</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
